BACKGROUND AND PURPOSE: The Na(+)/Ca(2+) exchanger (NCX) may play a key role in myocardial contractility. The operation of the NCX is affected by the action potential (AP) configuration and the intracellular Na(+) concentration. This study examined the effect of selective NCX inhibition by 0.1, 0.3 and 1.0 microM SEA0400 on the myocardial contractility in the setting of different AP configurations and different intracellular Na(+) concentrations in rabbit and rat hearts. EXPERIMENTAL APPROACH: The concentration-dependent effects of SEA0400 on I(Na/Ca) were studied in rat and rabbit ventricular cardiomyocytes using a patch clamp technique. Starling curves were constructed for isolated, Langendorff-perfused rat and rabbit hearts. The cardiac sarcolemmal NCX protein densities of both species were compared by immunohistochemistry. KEY RESULTS: SEA0400 inhibited I(Na/Ca) with similar efficacy in the two species; there was no difference between the inhibitions of the forward or reverse mode of the NCX in either species. SEA0400 increased the systolic and the developed pressure in the rat heart in a concentration-dependent manner, for example, 1.0 microM SEA0400 increased the maximum systolic pressures by 12% relative to the control, whereas it failed to alter the contractility in the rabbit heart. No interspecies difference was found in the cardiac sarcolemmal NCX protein densities. CONCLUSIONS AND IMPLICATIONS: NCX inhibition exerted a positive inotropic effect in the rat heart, but it did not influence the contractility of the rabbit heart. This implies that the AP configuration and the intracellular Na(+) concentration may play an important role in the contractility response to NCX inhibition.
BACKGROUND AND PURPOSE: The Na(+)/Ca(2+) exchanger (NCX) may play a key role in myocardial contractility. The operation of the NCX is affected by the action potential (AP) configuration and the intracellular Na(+) concentration. This study examined the effect of selective NCX inhibition by 0.1, 0.3 and 1.0 microM SEA0400 on the myocardial contractility in the setting of different AP configurations and different intracellular Na(+) concentrations in rabbit and rat hearts. EXPERIMENTAL APPROACH: The concentration-dependent effects of SEA0400 on I(Na/Ca) were studied in rat and rabbit ventricular cardiomyocytes using a patch clamp technique. Starling curves were constructed for isolated, Langendorff-perfused rat and rabbit hearts. The cardiac sarcolemmal NCX protein densities of both species were compared by immunohistochemistry. KEY RESULTS:SEA0400 inhibited I(Na/Ca) with similar efficacy in the two species; there was no difference between the inhibitions of the forward or reverse mode of the NCX in either species. SEA0400 increased the systolic and the developed pressure in the rat heart in a concentration-dependent manner, for example, 1.0 microM SEA0400 increased the maximum systolic pressures by 12% relative to the control, whereas it failed to alter the contractility in the rabbit heart. No interspecies difference was found in the cardiac sarcolemmal NCX protein densities. CONCLUSIONS AND IMPLICATIONS: NCX inhibition exerted a positive inotropic effect in the rat heart, but it did not influence the contractility of the rabbit heart. This implies that the AP configuration and the intracellular Na(+) concentration may play an important role in the contractility response to NCX inhibition.
Authors: Károly Acsai; Attila Kun; Attila S Farkas; Ferenc Fülöp; Norbert Nagy; Marianna Balázs; Norbert Szentandrássy; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth Journal: Eur J Pharmacol Date: 2007-07-31 Impact factor: 4.432
Authors: T Matsuda; N Arakawa; K Takuma; Y Kishida; Y Kawasaki; M Sakaue; K Takahashi; T Takahashi; T Suzuki; T Ota; A Hamano-Takahashi; M Onishi; Y Tanaka; K Kameo; A Baba Journal: J Pharmacol Exp Ther Date: 2001-07 Impact factor: 4.030
Authors: Candace Lee; Neeraj S Visen; Naranjan S Dhalla; Hoa Dinh Le; Michael Isaac; Platon Choptiany; Gil Gross; Alexander Omelchenko; Toshio Matsuda; Akemichi Baba; Kenzo Takahashi; Mark Hnatowich; Larry V Hryshko Journal: J Pharmacol Exp Ther Date: 2004-07-01 Impact factor: 4.030
Authors: Birgit Bölck; Götz Münch; Peter Mackenstein; Martin Hellmich; Ingo Hirsch; Hannes Reuter; Nadja Hattebuhr; Hans-Jörg Weig; Martin Ungerer; Klara Brixius; Robert H G Schwinger Journal: Am J Physiol Heart Circ Physiol Date: 2004-05-27 Impact factor: 4.733
Authors: Attila S Farkas; Péter Makra; Norbert Csík; Szabolcs Orosz; Michael J Shattock; Ferenc Fülöp; Tamás Forster; Miklós Csanády; Julius Gy Papp; András Varró; András Farkas Journal: Br J Pharmacol Date: 2009-02-16 Impact factor: 8.739
Authors: Norbert Nagy; Anita Kormos; Zsófia Kohajda; Áron Szebeni; Judit Szepesi; Piero Pollesello; Jouko Levijoki; Károly Acsai; László Virág; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739
Authors: Zsófia Hoyk; Melinda E Tóth; Nikolett Lénárt; Dóra Nagy; Brigitta Dukay; Alexandra Csefová; Ágnes Zvara; György Seprényi; András Kincses; Fruzsina R Walter; Szilvia Veszelka; Judit Vígh; Beáta Barabási; András Harazin; Ágnes Kittel; László G Puskás; Botond Penke; László Vígh; Mária A Deli; Miklós Sántha Journal: Front Cell Neurosci Date: 2018-10-25 Impact factor: 5.505
Authors: Petra Sántha; Szilvia Veszelka; Zsófia Hoyk; Mária Mészáros; Fruzsina R Walter; Andrea E Tóth; Lóránd Kiss; András Kincses; Zita Oláh; György Seprényi; Gábor Rákhely; András Dér; Magdolna Pákáski; János Kálmán; Ágnes Kittel; Mária A Deli Journal: Front Mol Neurosci Date: 2016-01-14 Impact factor: 5.639
Authors: Nils Bögeholz; Jan S Schulte; Sven Kaese; B Klemens Bauer; Paul Pauls; Dirk G Dechering; Gerrit Frommeyer; Joshua I Goldhaber; Uwe Kirchhefer; Lars Eckardt; Christian Pott; Frank U Müller Journal: Front Pharmacol Date: 2017-09-21 Impact factor: 5.810